Intramuscular Oxytocics: A Randomised Control Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

5,798

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

October 30, 2018

Conditions
Post Partum Haemorrhage
Interventions
DRUG

Carbetocin

The intervention is the administration of one dose of study drug to the recruited patient at the time of delivery. Carbetocin, listed here, is one of the of the three study drugs.

DRUG

Syntocinon

The intervention is the administration of one dose of study drug to the recruited patient at the time of delivery. Syntocinon, listed here, is one of the of the three study drugs.

DRUG

Syntometrine

The intervention is the administration of one dose of study drug to the recruited patient at the time of delivery. Syntometrine, listed here, is one of the of the three study drugs.

Trial Locations (5)

BS10 5NB

North Bristol NHS Trust, Bristol

GL1 3NN

Gloucestershire Hospitals NHS Trust, Gloucester

BA1 3NG

Royal United Hospital NHS Trust, Bath

Unknown

Nottingham University Hospitals NHS Trust, Nottingham

SN3 6BB

Great Western Hospital, Swindon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ferring Pharmaceuticals

INDUSTRY

collaborator

University of Bristol

OTHER

collaborator

University of the West of England

OTHER

collaborator

Royal United Hospital Bath NHS Trust

OTHER

collaborator

Gloucestershire Hospitals NHS Foundation Trust

OTHER

collaborator

University Hospitals Bristol and Weston NHS Foundation Trust

OTHER

lead

North Bristol NHS Trust

OTHER